Effect of Noncardiac Comorbidities on Quality of Life among Patients with Heart Failure - An Observational Study

Effect of Noncardiac Comorbidities on Quality of Life among Patients with Heart Failure - An Observational Study

Introduction: Heart failure (HF) is frequently associated with multiple cardiac and noncardiac comorbidities, with most requiring active management. Various studies using multiple tools iterate the association between various components of quality of life (QoL) in HF patients. Identifying comorbidit...

Full description

Saved in:

Bibliographic Details
Main Authors:	J. Anusha, Vishwanath Krishnamurthy, Varun V. Prakash, Madhu P. Raj, H. Aadithya Shyllesh, G.R. Bharath
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2025-07-01
Series:	APIK Journal of Internal Medicine
Subjects:	heart failure heart failure with preserved ejection fraction heart failure with reduced ejection fraction kansas city cardiomyopathy questionnaire
Online Access:	https://journals.lww.com/10.4103/ajim.ajim_8_25
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effect of dapagliflozin in paroxysmal atrial fibrillation combined with heart failure with preserved ejection fraction: a randomized controlled trial
by: Xiaoyu LIAN, et al.
Published: (2025-06-01)

Gender‐specific risks for incident cancer in patients with different heart failure phenotypes
by: Qin‐Fen Chen, et al.
Published: (2025-02-01)

Improved cardiac and venous pressures during hospital stay in patients with acute heart failure: an echocardiography and biomarkers study
by: Eiichi Akiyama, et al.
Published: (2020-06-01)

Impact of Obstructive Sleep Apnea in Patients with Acute Heart Failure: A Nationwide Cohort Study
by: Abdulmajeed Alharbi, et al.
Published: (2024-11-01)

Correlation of β-adrenergic reactivity of erythrocyte membranes with clinical characteristics of patients with coronary artery disease and HF with preserved and reduced ejection fraction
by: E. F. Muslimova, et al.
Published: (2025-01-01)

Lipoprotein(a) and Heart Failure Among Black and White Participants in Atherosclerosis Risk in Communities Study, Framingham Offspring Study, and Multi‐Ethnic Study of Atherosclerosis: The Pooling Project
by: Sarah Nomura, et al.
Published: (2025-06-01)

Prediction model of rehospitalization and mortality in heart failure patients with preserved and mildly reduced ejection fraction: the AD2NNER risk score
by: Flavia-Mihaela Stoiculescu, et al.
Published: (2025-07-01)

Clinical management of heart failure with improved ejection fraction: treatment and maintenance
by: XU Tianyun, et al.
Published: (2025-04-01)

Left atrioventricular coupling index measured by echocardiography in heart failure with preserved ejection fraction
by: Hai Nguyen Ngoc Dang, et al.
Published: (2025-07-01)

Characterizing Heart Failure Across the Spectrum of the Preserved Ejection Fraction: Does Heart Failure With Supranormal Ejection Fraction Exist? Data From the Swedish Heart Failure Registry
by: Laura Landucci, et al.
Published: (2025-03-01)

Prognostic significance of NT-proBNP and sST2 in patients with heart failure with preserved and mildly reduced ejection fraction
by: V. I. Podzolkov, et al.
Published: (2023-10-01)

Left Ventricular Ejection Fraction in Heart Failure: Crazy, Stupid Love—and Maybe, Redemption
by: Milton Packer
Published: (2024-04-01)

Phenotypic clusters in heart failure with preserved and mid-range ejection fraction: new data and perspectives
by: O. V. Tsygankova, et al.
Published: (2021-05-01)

New possibilities in pharmacotherapy for the heart failure with reduced ejection fraction treatment in patients with recent deterioration
by: I. V. Gribkova
Published: (2024-03-01)

Elevating Expectations: Vericiguat in Heart Failure with Reduced Ejection Fraction
by: Pushpraj Patel, et al.
Published: (2024-12-01)

Heart Failure with Preserved Ejection Fraction in Egypt: An Expert Opinion
by: Magdy Abdelhamid, et al.
Published: (2025-03-01)

Heart failure with preserved left ventricular ejection fraction – clinical perspectives
by: Małgorzata Niemiec, et al.
Published: (2025-07-01)

Circulating Cell-Free Nuclear DNA Predicted an Improvement of Systolic Left Ventricular Function in Individuals with Chronic Heart Failure with Reduced Ejection Fraction
by: Tetiana Berezina, et al.
Published: (2024-10-01)

Catestatin as a predictor for cardiac death in heart failure with mildly reduced and preserved ejection fraction
by: Song‐Yun Chu, et al.
Published: (2025-02-01)

Obesity paradox in chronic heart failure with moderately reduced or preserved left ventricular ejection fraction: impact on a prognosis for patients according to a five-year follow-up
by: P. P. Bidzilya, et al.
Published: (2023-07-01)

Characteristics, outcomes and the necessity of continued guideline-directed medical therapy in patients with heart failure with improved ejection fraction
by: Qin-Fen Chen, et al.
Published: (2025-12-01)

SHengXIaN-QuYu DEcoction in the Treatment of Heart Failure with Reduced and Mildly-Reduced Ejection Fraction (SHINE-HF): rationale and design for a multicenter randomized controlled trial
by: Lina Feng, et al.
Published: (2025-06-01)

Importance of non‐cardiovascular comorbidities in atrial fibrillation and heart failure with preserved ejection fraction
by: Yasuhiro Hamatani, et al.
Published: (2025-02-01)

The impact of glomerular filtration rate on short-term outcome in elderly patients with heart failure with preserved ejection fraction
by: Giuseppe Delli Carpini, et al.
Published: (2025-07-01)

Low-intensity inflammation as a manifestation of comorbidity and a factor in the unfavorable clinical course of heart failure with preserved ejection fraction
by: K. N. Vitt, et al.
Published: (2024-03-01)

In‐Hospital or Out‐of‐Hospital Initiation of Sacubitril/Valsartan Versus Valsartan in Patients With Mildly Reduced or Preserved Ejection Fraction After A Worsening Heart Failure Event: The PARAGLIDE‐HF Trial
by: Nina Nouhravesh, et al.
Published: (2025-03-01)

Features of phenotyping patients with heart failure with preserved ejection fraction
by: E. K. Serezhina, et al.
Published: (2023-09-01)

About the classification of heart failure
by: A. S. Galyavich, et al.
Published: (2023-09-01)

Features of chronic heart failure depending on the left ventricular ejection fraction
by: A. G. Dushina, et al.
Published: (2019-03-01)

Results of the Russian Society of Cardiology survey "Chronic heart failure. Unsolved issues"
by: O. B. Irtyuga, et al.
Published: (2024-06-01)

First report of the clinical characteristics and outcomes of cardiac amyloidosis in Saudi Arabia
by: Omar Ahmad, et al.
Published: (2024-12-01)

Prognostic Value of Epicardial Adipose Tissue in Heart Failure With Mid‐Range and Preserved Ejection Fraction: A Multicenter Study
by: Wenxian Wang, et al.
Published: (2024-12-01)

Chronic Heart Failure with Preserved Ejection Fraction in A Comorbid Patient: Issues in Verification of A «Difficult» Diagnosis
by: O. V. Ponomareva, et al.
Published: (2025-05-01)

Dynamics of heart failure markers and cardiac reverse remodeling in patients receiving cardiac contractility modulation therapy
by: M. A. Vander, et al.
Published: (2021-02-01)

Editorial: Advanced therapeutic strategies and safety profiles in heart failure with reduced ejection fraction: contextualizing recent findings
by: Maria del Carmen Asensio-Lopez, et al.
Published: (2025-04-01)

Molecular biomarker profile of heart failure with mid-range and preserved ejection fraction in patients with type 2 diabetes
by: D. A. Lebedev, et al.
Published: (2020-11-01)

Structural and functional changes in the heart and clinical features of heart failure with preserved left ventricular ejection fraction in patients after myocardial infarction, comorbided with arterial hypertension
by: V. D. Syvolap, et al.
Published: (2013-12-01)

The Physical Activity in the Management of Heart Failure with Reduced Ejection Fraction A Review of Current Evidence and Recommendations
by: Natalia Smyl, et al.
Published: (2025-07-01)

Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory risk
by: Robert J.H. Miller, et al.
Published: (2022-06-01)

Markers of heart failure with preserved ejection fraction in patients with unexplained dyspnea
by: A. A. Ivanova, et al.
Published: (2023-11-01)